Lexeo Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $139.8M
Liabilities Breakdown FY2023
Total Liabilities: $26.3M
Asset Breakdown
Total Assets: $139.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $121.5M | 86.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $17.3M | 12.4% |
Liabilities Breakdown
Total Liabilities: $26.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.8M | 14.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $22.5M | 85.6% |